Abbott Laboratories Share Price Today: Live Updates & Key Insights

Abbott Laboratories share price today is $106.3, up -1.61%. The stock opened at $107.04 against the previous close of $107.19, with an intraday high of $107.79 and low of $105.4.

Abbott Laboratories Share Price Chart

Abbott Laboratories

us-stock
To Invest in {{usstockname}}
us-stock

Abbott Laboratories Share Price Performance

$106.3 -0.0161(-1.61%) ABT at 23 Mar 2026 11:51 AM Medical Devices
Lowest Today 105.4
Highest Today 107.79
Today’s Open 107.04
Prev. Close 107.19
52 Week High 137.13
52 Week Low 105.27
Day’s Range: Low 105.4 High 107.79
52-Week Range: Low 105.27 High 137.13
1 day return -
1 Week return -3.96
1 month return -8.4
3 month return -15.65
6 month return -22.75
1 year return -16.97
3 year return +8.98
5 year return -13.06
10 year return -

Abbott Laboratories Institutional Holdings

Vanguard Group Inc 10.10

BlackRock Inc 8.15

State Street Corp 4.50

Capital Research & Mgmt Co - Division 3 3.64

JPMorgan Chase & Co 3.38

Vanguard Total Stock Mkt Idx Inv 3.15

Vanguard 500 Index Investor 2.55

J Stern & Co LLP 2.26

Capital Research Global Investors 2.25

Morgan Stanley - Brokerage Accounts 2.22

Geode Capital Management, LLC 2.21

NORGES BANK 1.35

Wellington Management Company LLP 1.35

iShares Core S&P 500 ETF 1.28

Fidelity 500 Index 1.27

Bank of America Corp 1.20

State Street® SPDR® S&P 500® ETF 1.18

Northern Trust Corp 1.18

American Funds Washington Mutual A 1.13

Capital Group Wash Mutual Invtrs Comp 1.13

T. Rowe Price Investment Management,Inc. 1.02

Wells Fargo & Co 0.96

The Goldman Sachs Group Inc 0.93

American Funds Invmt Co of Amer A 0.92

Capital Group Investment Co of Amer Comp 0.92

Vanguard Value Index Inv 0.92

T. Rowe Price Associates, Inc. 0.91

Massachusetts Financial Services Company 0.84

Amvescap Plc. 0.80

State Farm Mutual Automobile Ins Co 0.78

State Street®HlthCrSelSectSPDR®ETF 0.74

American Funds American Mutual A 0.67

Capital Group American Mutual Comp 0.67

Vanguard Institutional Index I 0.57

American Funds Capital Income Bldr A 0.55

Vanguard Dividend Appreciation ETF 0.55

American Funds American Balanced A 0.53

State St S&P 500® Indx SL Cl III 0.53

Vanguard Institutional 500 Index Trust 0.45

American Funds Capital World Gr&Inc A 0.43

Abbott Laboratories Market Status

Strong Buy: 12

Buy: 7

Hold: 9

Sell: 0

Strong Sell: 0

Abbott Laboratories Fundamentals

Market Cap 183256.04 M

PB Ratio 3.5154

PE Ratio 28.8142

Enterprise Value 188176.19 M

Total Assets 86713.00 M

Volume 81271290

Abbott Laboratories Company Financials

Annual Revenue FY25:44328000000 44328.0M, FY24:41950000000 41950.0M, FY23:39959000000 39959.0M, FY22:43653000000 43653.0M, FY21:43075000000 43075.0M

Annual Profit FY25:24607000000 24607.0M, FY24:23244000000 23244.0M, FY23:21947000000 21947.0M, FY22:24511000000 24511.0M, FY21:24538000000 24538.0M

Annual Net worth FY25:6524000000 6524.0M, FY24:13402000000 13402.0M, FY23:5162000000 5162.0M, FY22:6933000000 6933.0M, FY21:7071000000 7071.0M

Quarterly Revenue Q4/2025:11459000000 11459.0M, Q3/2025:11369000000 11369.0M, Q2/2025:11142000000 11142.0M, Q1/2025:10358000000 10358.0M, Q4/2024:10974000000 10974.0M

Quarterly Profit Q4/2025:6537000000 6537.0M, Q3/2025:6338000000 6338.0M, Q2/2025:6288000000 6288.0M, Q1/2025:5444000000 5444.0M, Q4/2024:6032000000 6032.0M

Quarterly Net worth Q4/2025:1776000000 1776.0M, Q3/2025:1644000000 1644.0M, Q2/2025:1779000000 1779.0M, Q1/2025:1325000000 1325.0M, Q4/2024:9229000000 9229.0M

About Abbott Laboratories & investment objective

Company Information Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Organisation Medical Devices

Employees 115000

Industry Medical Devices

CEO Mr. Robert B. Ford

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Abbott Laboratories FAQs

What is the share price of Abbott Laboratories today?

The current share price of Abbott Laboratories is $106.3.

Can I buy Abbott Laboratories shares in India?

Yes, Indian investors can buy Abbott Laboratories shares by opening an international trading and demat account with Motilal Oswal.

How to buy Abbott Laboratories shares in India?

You can easily invest in Abbott Laboratories shares from India by:

Can I buy fractional shares of Abbott Laboratories?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Abbott Laboratories?

Abbott Laboratories has a market cap of $183256.04 M.

In which sector does Abbott Laboratories belong?

Abbott Laboratories operates in the Medical Devices sector.

What documents are required to invest in Abbott Laboratories stocks?

To invest, you typically need:

What is the PE and PB ratio of Abbott Laboratories?

The PE ratio of Abbott Laboratories is 28.81 and the PB ratio is 3.52.